FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola™ Coronary Laser IVL System
FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola™ Coronary Laser IVL System
Early-stage medical device company advancing next-generation intravascular lithotripsy (IVL) technology for peripheral artery disease. Received FDA IDE approval for pivotal trial of Artero system.
Pivotal trial enrollment begins
FastWave Medical Reports 96.4% Procedural Success in First-in-Human Study of Sola™ Coronary Laser IVL System
FastWave Medical Gains FDA IDE Approval to Begin Pivotal Trial of Artero™ Peripheral IVL System
Chief Executive Officer
VP R&D